The paradoxical role of inflammation in cardiac repair and regeneration

Journal of Cardiovascular Translational Research

Volumn 3, Issue 4, 2010, Pages 410-416

  Jiang, Bingbing ^a   Liao, Ronglih ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cell Therapy; Cytokine; Innate Immune; Myocardial Infarction; Stem Cell

Indexed keywords

CYTOKINE; GROWTH FACTOR; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED WEAK INDUCER OF APOPTOSIS; UNCLASSIFIED DRUG;

APOPTOSIS; CELL DEATH; CYTOKINE RESPONSE; ENZYME ACTIVATION; ENZYME REGULATION; ENZYME REPRESSION; HEART FAILURE; HEART INFARCTION; HEART INJURY; HEART VENTRICLE REMODELING; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; TISSUE REGENERATION; TISSUE REPAIR;

ANIMALS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CYTOKINES; HEART FAILURE; HMGB1 PROTEIN; HUMANS; INFLAMMATION; INTERLEUKIN-1; INTERLEUKIN-6; MACROPHAGES; MYOCARDIAL INFARCTION; MYOCARDIUM; REGENERATION; STEM CELLS; TUMOR NECROSIS FACTOR-ALPHA; TUMOR NECROSIS FACTORS; UP-REGULATION;

EID: 77955510430     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-010-9193-7     Document Type: Review

References (97)

1. D Lloyd-Jones R Adams M Carnethon G De Simone TB Ferguson K Flegal, et al. 2009 Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 119 480 486 10.1161/CIRCULATIONAHA.108.191259 19171871
2. J Kajstura A Leri N Finato C Di Loreto CA Beltrami P Anversa 1998 Myocyte proliferation in end-stage cardiac failure in humans Proceedings of the National Academy of Sciences of the United States of America 95 8801 8805 10.1073/pnas.95.15.8801 9671759 1:CAS:528:DyaK1cXkvFalsbc%3D (Pubitemid 28350569)
3. KL Laugwitz A Moretti J Lam P Gruber Y Chen S Woodard, et al. 2005 Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages Nature 433 647 653 10.1038/nature03215 15703750 1:CAS:528:DC%2BD2MXhtFaqsb4%3D (Pubitemid 40282999)
4. A Moretti L Caron A Nakano JT Lam A Bernshausen Y Chen, et al. 2006 Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification Cell 127 1151 1165 10.1016/j.cell.2006.10.029 17123592 1:CAS:528:DC%2BD2sXhs1egtA%3D%3D (Pubitemid 44895618)
5. K Takahashi K Tanabe M Ohnuki M Narita T Ichisaka K Tomoda, et al. 2007 Induction of pluripotent stem cells from adult human fibroblasts by defined factors Cell 131 861 872 10.1016/j.cell.2007.11.019 18035408 1:CAS:528:DC%2BD2sXhsVCntbbK (Pubitemid 350138099)
6. PC Hsieh VF Segers ME Davis C MacGillivray J Gannon JD Molkentin, et al. 2007 Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury Natural Medicines 13 970 974 10.1038/nm1618 1:CAS:528:DC%2BD2sXos1Cjsbk%3D (Pubitemid 47222045)
7. J Zhang GF Wilson AG Soerens CH Koonce J Yu SP Palecek, et al. 2009 Functional cardiomyocytes derived from human induced pluripotent stem cells Circulation Research 104 e30 e41 10.1161/CIRCRESAHA.108.192237 19213953 1:CAS:528:DC%2BD1MXhvFejtb4%3D
8. O Bergmann RD Bhardwaj S Bernard S Zdunek F Barnabe-Heider S Walsh, et al. 2009 Evidence for cardiomyocyte renewal in humans Science 324 98 102 10.1126/science.1164680 19342590 1:CAS:528:DC%2BD1MXjvVajsbc%3D
9. SJ Leibovich R Ross 1976 A macrophage-dependent factor that stimulates the proliferation of fibroblasts in vitro The American Journal of Pathology 84 501 514 961824 1:STN:280:DyaE283nsFehtw%3D%3D
10. SA Eming M Hammerschmidt T Krieg A Roers 2009 Interrelation of immunity and tissue repair or regeneration Seminars in Cell & Developmental Biology 20 517 527 10.1016/j.semcdb.2009.04.009 1:CAS:528:DC%2BD1MXotFOqsr8%3D
11. RB Jennings C Steenbergen Jr KA Reimer 1995 Myocardial ischemia and reperfusion Monographs in Pathology 37 47 80 7603485 1:STN:280: DyaK2MzislWjtw%3D%3D
12. P Matzinger 1994 Tolerance, danger, and the extended family Annual Review of Immunology 12 991 1045 8011301 1:STN:280:DyaK2c3otVOqsA%3D%3D
13. S Akira 2006 TLR signaling Current Topics in Microbiology and Immunology 311 1 16 10.1007/3-540-32636-7-1 17048703 1:CAS:528:DC%2BD28Xht1WrsbjE
14. W Chao 2009 Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart American Journal of Physiology. Heart and Circulatory Physiology 296 H1 H12 10.1152/ajpheart.00995.2008 19011041 1:CAS:528:DC%2BD1MXhtVOiurk%3D
15. CJ Chen H Kono D Golenbock G Reed S Akira KL Rock 2007 Identification of a key pathway required for the sterile inflammatory response triggered by dying cells Natural Medicines 13 851 856 10.1038/nm1603 1:CAS:528:DC%2BD2sXnsFWmtrk%3D (Pubitemid 47038190)
16. V Petrilli S Papin C Dostert A Mayor F Martinon J Tschopp 2007 Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration Cell Death and Differentiation 14 1583 1589 10.1038/sj.cdd.4402195 17599094 1:CAS:528:DC%2BD2sXptFymurg%3D (Pubitemid 47278844)
17. SB Willingham IC Allen DT Bergstralh WJ Brickey MT Huang DJ Taxman, et al. 2009 NLRP3 (NALP3, Cryopyrin) facilitates in vivo caspase-1 activation, necrosis, and HMGB1 release via inflammasome-dependent and -independent pathways Journal of Immunology 183 2008 2015 10.4049/jimmunol.0900138 1:CAS:528:DC%2BD1MXoslCrsb4%3D
18. T Bergsbaken SL Fink BT Cookson 2009 Pyroptosis: host cell death and inflammation Nature Reviews. Microbiology 7 99 109 10.1038/nrmicro2070 19148178 1:CAS:528:DC%2BD1MXlvFynug%3D%3D
19. L Franchi T Eigenbrod R Munoz-Planillo G Nunez 2009 The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis Nature Immunology 10 241 247 10.1038/ni.1703 19221555 1:CAS:528:DC%2BD1MXhvFKjtLo%3D
20. H Li A Ambade F Re 2009 Cutting edge: necrosis activates the NLRP3 inflammasome Journal of Immunology 183 1528 1532 10.4049/jimmunol.0901080 1:CAS:528:DC%2BD1MXoslCktbk%3D
21. K Yamasaki J Muto KR Taylor AL Cogen D Audish J Bertin, et al. 2009 NLRP3/cryopyrin is necessary for interleukin-1beta (IL-1beta) release in response to hyaluronan, an endogenous trigger of inflammation in response to injury The Journal of Biological Chemistry 284 12762 12771 10.1074/jbc. M806084200 19258328 1:CAS:528:DC%2BD1MXltlenu7s%3D
22. A Tsung R Sahai H Tanaka A Nakao MP Fink MT Lotze, et al. 2005 The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion The Journal of Experimental Medicine 201 1135 1143 10.1084/jem.20042614 15795240 1:CAS:528:DC%2BD2MXjtFWls7s%3D (Pubitemid 40524681)
23. H Wu G Chen KR Wyburn J Yin P Bertolino JM Eris, et al. 2007 TLR4 activation mediates kidney ischemia/reperfusion injury Journal of Clinical Investigation 117 2847 2859 10.1172/JCI31008 17853945 1:CAS:528: DC%2BD2sXhtFCnt73E (Pubitemid 47529615)
24. KP Mollen RJ Anand A Tsung JM Prince RM Levy TR Billiar 2006 Emerging paradigm: toll-like receptor 4-sentinel for the detection of tissue damage Shock 26 430 437 10.1097/01.shk.0000228797.41044.08 17047512 1:CAS:528: DC%2BD28Xht1eht7vP (Pubitemid 44632271)
25. Y Takeishi I Kubota 2009 Role of Toll-like receptor mediated signaling pathway in ischemic heart Frontiers in Bioscience 14 2553 2558 10.2741/3397 19273219 1:CAS:528:DC%2BD1MXltFeitLk%3D
26. P Rovere-Querini A Capobianco P Scaffidi B Valentinis F Catalanotti M Giazzon, et al. 2004 HMGB1 is an endogenous immune adjuvant released by necrotic cells EMBO Reports 5 825 830 10.1038/sj.embor.7400205 15272298 1:CAS:528:DC%2BD2cXmtFOhur8%3D (Pubitemid 39199174)
27. DJ Kaczorowski A Nakao R Vallabhaneni KP Mollen R Sugimoto J Kohmoto, et al. 2009 Mechanisms of Toll-like receptor 4 (TLR4)-mediated inflammation after cold ischemia/reperfusion in the heart Transplantation 87 1455 1463 10.1097/TP.0b013e3181a36e5e 19461481 1:CAS:528:DC%2BD1MXmtFKhs7w%3D
28. S Oozawa S Mori T Kanke H Takahashi K Liu Y Tomono, et al. 2008 Effects of HMGB1 on ischemia-reperfusion injury in the rat heart Circulation Journal 72 1178 1184 10.1253/circj.72.1178 18577832 1:CAS:528:DC%2BD1cXovFelt74%3D (Pubitemid 351957089)
29. M Andrassy HC Volz JC Igwe B Funke SN Eichberger Z Kaya, et al. 2008 High-mobility group box-1 in ischemia-reperfusion injury of the heart Circulation 117 3216 3226 10.1161/CIRCULATIONAHA.108.769331 18574060 1:CAS:528:DC%2BD1cXnt1ehs7g%3D
30. AE Decleves N Caron D Nonclercq A Legrand G Toubeau R Kramp, et al. 2006 Dynamics of hyaluronan, CD44, and inflammatory cells in the rat kidney after ischemia/reperfusion injury International Journal of Molecular Medicine 18 83 94 16786159 1:CAS:528:DC%2BD28Xnt1CnsLw%3D
31. KR Taylor JM Trowbridge JA Rudisill CC Termeer JC Simon RL Gallo 2004 Hyaluronan fragments stimulate endothelial recognition of injury through TLR4 The Journal of Biological Chemistry 279 17079 17084 10.1074/jbc.M310859200 14764599 1:CAS:528:DC%2BD2cXjt1Ggt7k%3D (Pubitemid 38560463)
32. KR Taylor K Yamasaki KA Radek A Di Nardo H Goodarzi D Golenbock, et al. 2007 Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on Toll-like receptor 4, CD44, and MD-2 The Journal of Biological Chemistry 282 18265 18275 10.1074/jbc.M606352200 17400552 1:CAS:528:DC%2BD2sXmsVOlu7k%3D (Pubitemid 47100227)
33. GB Johnson GJ Brunn Y Kodaira JL Platt 2002 Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4 Journal of Immunology 168 5233 5239 1:CAS:528:DC%2BD38XjslSjtb4%3D
34. JW Celie NW Rutjes ED Keuning R Soininen R Heljasvaara T Pihlajaniemi, et al. 2007 Subendothelial heparan sulfate proteoglycans become major L-selectin and monocyte chemoattractant protein-1 ligands upon renal ischemia/reperfusion The American Journal of Pathology 170 1865 1878 10.2353/ajpath.2007.070061 17525255 1:CAS:528:DC%2BD2sXntlOht70%3D (Pubitemid 47339261)
35. KH Mills A Dunne 2009 Immune modulation: IL-1, master mediator or initiator of inflammation Natural Medicines 15 1363 1364 10.1038/nm1209-1363 1:CAS:528:DC%2BD1MXhsFWksLjJ
36. F Martinon K Hofmann J Tschopp 2001 The pyrin domain: a possible member of the death domain-fold family implicated in apoptosis and inflammation Current Biology 11 R118 R120 10.1016/S0960-9822(01)00056-2 11250163 1:CAS:528:DC%2BD3MXhsFWht7s%3D (Pubitemid 32185314)
37. WJ Fairbrother NC Gordon EW Humke KM O'Rourke MA Starovasnik JP Yin, et al. 2001 The PYRIN domain: a member of the death domain-fold superfamily Protein Science 10 1911 1918 10.1110/ps.13801 11514682 1:CAS:528:DC%2BD3MXmsFSgu74%3D (Pubitemid 32848788)
38. T Fernandes-Alnemri J Wu JW Yu P Datta B Miller W Jankowski, et al. 2007 The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation Cell Death and Differentiation 14 1590 1604 10.1038/sj.cdd.4402194 17599095 1:CAS:528:DC%2BD2sXptFymurs%3D (Pubitemid 47278845)
39. T Kubota CF McTiernan CS Frye AJ Demetris AM Feldman 1997 Cardiac-specific overexpression of tumor necrosis factor-alpha causes lethal myocarditis in transgenic mice Journal of Cardiac Failure 3 117 124 10.1016/S1071-9164(97)90045-2 9220311 1:CAS:528:DyaK2sXmsVeltb8%3D
40. B Bozkurt SB Kribbs FJ Clubb Jr LH Michael VV Didenko PJ Hornsby, et al. 1998 Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats Circulation 97 1382 1391 9577950 1:CAS:528:DyaK1cXis1KqtL0%3D
41. T Yokoyama L Vaca RD Rossen W Durante P Hazarika DL Mann 1993 Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart Journal of Clinical Investigation 92 2303 2312 10.1172/JCI116834 8227345 1:CAS:528:DyaK2cXivFSltw%3D%3D
42. SM Dunlay SA Weston MM Redfield JM Killian VL Roger 2008 Tumor necrosis factor-alpha and mortality in heart failure: a community study Circulation 118 625 631 10.1161/CIRCULATIONAHA.107.759191 18645056 1:CAS:528: DC%2BD1cXptFSltro%3D
43. M Tanno DA Gorog M Bellahcene X Cao RA Quinlan MS Marber 2003 Tumor necrosis factor-induced protection of the murine heart is independent of p38-MAPK activation Journal of Molecular and Cellular Cardiology 35 1523 1527 10.1016/j.yjmcc.2003.09.019 14654378 1:CAS:528:DC%2BD3sXpsVSnt7k%3D (Pubitemid 37491195)
44. N Yamashita S Hoshida K Otsu N Taniguchi T Kuzuya M Hori 2000 The involvement of cytokines in the second window of ischaemic preconditioning British Journal of Pharmacology 131 415 422 10.1038/sj.bjp.0703594 11015290 1:CAS:528:DC%2BD3cXnsVygt70%3D
45. B Dawn Y Guo A Rezazadeh OL Wang AB Stein G Hunt, et al. 2004 Tumor necrosis factor-alpha does not modulate ischemia/reperfusion injury in naive myocardium but is essential for the development of late preconditioning Journal of Molecular and Cellular Cardiology 37 51 61 10.1016/j.yjmcc.2004.03.012 15242735 1:CAS:528:DC%2BD2cXlsFyntbo%3D (Pubitemid 38900528)
46. Y Higuchi CF McTiernan CB Frye BS McGowan TO Chan AM Feldman 2004 Tumor necrosis factor receptors 1 and 2 differentially regulate survival, cardiac dysfunction, and remodeling in transgenic mice with tumor necrosis factor-alpha-induced cardiomyopathy Circulation 109 1892 1897 10.1161/01.CIR.0000124227.00670.AB 15051641 1:CAS:528:DC%2BD2cXivFKmsbo%3D (Pubitemid 38509125)
47. RS Al-Lamki AP Brookes J Wang MJ Reid J Parameshwar MJ Goddard, et al. 2009 TNF receptors differentially signal and are differentially expressed and regulated in the human heart American Journal of Transplantation 9 2679 2696 10.1111/j.1600-6143.2009.02831.x 19788501 1:CAS:528:DC%2BC3cXhsFClsLg%3D
48. W Declercq T Vanden Berghe P Vandenabeele 2009 RIP kinases at the crossroads of cell death and survival Cell 138 229 232 10.1016/j.cell.2009.07. 006 19632174 1:CAS:528:DC%2BD1MXhtVSgtrzK
49. Whelan, R. S., Kaplinskiy, V., & Kitsis, R. N. Cell death in the pathogenesis of heart disease: mechanisms and significance. Annu Rev Physiol, 72, 19-44.
50. S He L Wang L Miao T Wang F Du L Zhao, et al. 2009 Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha Cell 137 1100 1111 10.1016/j.cell.2009.05.021 19524512 1:CAS:528:DC%2BD1MXps1eiu70%3D
51. YS Cho S Challa D Moquin R Genga TD Ray M Guildford, et al. 2009 Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation Cell 137 1112 1123 10.1016/j.cell.2009. 05.037 19524513 1:CAS:528:DC%2BD1MXps1eiu7o%3D
52. DJ Mahoney HH Cheung RL Mrad S Plenchette C Simard E Enwere, et al. 2008 Both cIAP1 and cIAP2 regulate TNFalpha-mediated NF-kappaB activation Proceedings of the National Academy of Sciences of the United States of America 105 11778 11783 10.1073/pnas.0711122105 18697935
53. E Varfolomeev T Goncharov AV Fedorova JN Dynek K Zobel K Deshayes, et al. 2008 c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)-induced NF-kappaB activation The Journal of Biological Chemistry 283 24295 24299 10.1074/jbc.C800128200 18621737 1:CAS:528:DC%2BD1cXhtVGktb7E
54. Shembade, N., Ma, A., & Harhaj, E. W. Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes. Science, 327, 1135-1139.
55. NS Wilson V Dixit A Ashkenazi 2009 Death receptor signal transducers: nodes of coordination in immune signaling networks Nature Immunology 10 348 355 10.1038/ni.1714 19295631 1:CAS:528:DC%2BD1MXjtlymsLw%3D
56. L Wang F Du X Wang 2008 TNF-alpha induces two distinct caspase-8 activation pathways Cell 133 693 703 10.1016/j.cell.2008.03.036 18485876 1:CAS:528:DC%2BD1cXmsVOru78%3D (Pubitemid 351636305)
57. IE Wertz KM O'Rourke H Zhou M Eby L Aravind S Seshagiri, et al. 2004 De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling Nature 430 694 699 10.1038/nature02794 15258597 1:CAS:528: DC%2BD2cXmt1Gisb8%3D (Pubitemid 39061687)
58. CA Dinarello 2009 Immunological and inflammatory functions of the interleukin-1 family Annual Review of Immunology 27 519 550 10.1146/annurev. immunol.021908.132612 19302047 1:CAS:528:DC%2BD1MXlsFSltrc%3D
59. CJ Chen Y Shi A Hearn K Fitzgerald D Golenbock G Reed, et al. 2006 MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals Journal of Clinical Investigation 116 2262 2271 10.1172/JCI28075 16886064 1:CAS:528:DC%2BD28XnvF2mtL8%3D (Pubitemid 44162336)
60. MD Mitchell RE Laird RD Brown CS Long 2007 IL-1beta stimulates rat cardiac fibroblast migration via MAP kinase pathways American Journal of Physiology. Heart and Circulatory Physiology 292 H1139 H1147 10.1152/ajpheart.00881.2005 17085539 1:CAS:528:DC%2BD2sXjt1GntLs%3D
61. M Bujak NG Frangogiannis 2009 The role of IL-1 in the pathogenesis of heart disease Archivum Immunologiae et Therapiae Experimentalis (Warsz) 57 165 176 10.1007/s00005-009-0024-y 1:CAS:528:DC%2BD1MXptFCqu7s%3D
62. M Tamaru K Tomura S Sakamoto K Tezuka T Tamatani S Narumi 1998 Interleukin-1beta induces tissue- and cell type-specific expression of adhesion molecules in vivo Arteriosclerosis, Thrombosis, and Vascular Biology 18 1292 1303 9714137 1:CAS:528:DyaK1cXlvVCgtbY%3D
63. NG Frangogiannis 2008 The immune system and cardiac repair Pharmacological Research 58 88 111 10.1016/j.phrs.2008.06.007 18620057 1:CAS:528:DC%2BD1cXht1ejtLvO
64. GC Gurtner S Werner Y Barrandon MT Longaker 2008 Wound repair and regeneration Nature 453 314 321 10.1038/nature07039 18480812 1:CAS:528:DC%2BD1cXlvV2qtbk%3D (Pubitemid 351693137)
65. NG Frangogiannis KA Youker ML Entman 1996 The role of the neutrophil in myocardial ischemia and reperfusion EXS 76 263 284 8805800 1:CAS:528: DyaK28Xmtlaqur0%3D
66. P Blyszczuk G Kania T Dieterle RR Marty A Valaperti C Berthonneche, et al. 2009 Myeloid differentiation factor-88/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy Circulation Research 105 912 920 10.1161/CIRCRESAHA.109.199802 19762681 1:CAS:528:DC%2BD1MXhsVCiurvM
67. A Bonetti M Marchini F Ortolani 2008 Immunolocalization of interleukin-1 receptor antagonist in healthy and infarcted myocardium Histology and Histopathology 23 1093 1102 18581280 1:STN:280:DC%2BD1cvhtFahsA%3D%3D
68. A Abbate FN Salloum E Vecile A Das NN Hoke S Straino, et al. 2008 Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction Circulation 117 2670 2683 10.1161/CIRCULATIONAHA.107.740233 18474815 1:CAS:528:DC%2BD1cXlvVCntrs%3D
69. K Suzuki B Murtuza RT Smolenski IA Sammut N Suzuki Y Kaneda, et al. 2001 Overexpression of interleukin-1 receptor antagonist provides cardioprotection against ischemia-reperfusion injury associated with reduction in apoptosis Circulation 104 I308 I303 10.1161/hc3601.093987 11568074 1:CAS:528: DC%2BD3MXnsFOltbs%3D
70. D Kamimura K Ishihara T Hirano 2003 IL-6 signal transduction and its physiological roles: the signal orchestration model Reviews of Physiology Biochemistry and Pharmacology 149 1 38 10.1007/s10254-003-0012-2 1:CAS:528:DC%2BD2cXitFSluro%3D
71. I Banerjee JW Fuseler AR Intwala TA Baudino 2009 IL-6 loss causes ventricular dysfunction, fibrosis, reduced capillary density, and dramatically alters the cell populations of the developing and adult heart American Journal of Physiology. Heart and Circulatory Physiology 296 H1694 H1704 10.1152/ajpheart.00908.2008 19234091 1:CAS:528:DC%2BD1MXlvFansLg%3D
72. B Dawn YT Xuan Y Guo A Rezazadeh AB Stein G Hunt, et al. 2004 IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2 Cardiovascular Research 64 61 71 10.1016/j.cardiores.2004.05.011 15364614 1:CAS:528:DC%2BD2cXnsFGltb8%3D (Pubitemid 39208923)
73. Novoyatleva, T., Diehl, F., van Amerongen, M. J., Patra, C., Ferrazzi, F., Bellazzi, R., et al. (2009). TWEAK is a positive regulator of cardiomyocyte proliferation. Cardiovasc Res.
74. M Jain A Jakubowski L Cui J Shi L Su M Bauer, et al. 2009 A novel role for tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in the development of cardiac dysfunction and failure Circulation 119 2058 2068 10.1161/CIRCULATIONAHA.108.837286 19349318 1:CAS:528:DC%2BD1MXksVCku7Y%3D
75. S Mitola M Belleri C Urbinati D Coltrini B Sparatore M Pedrazzi, et al. 2006 Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine Journal of Immunology 176 12 15 1:CAS:528: DC%2BD2MXhtlagt7bI
76. F Limana A Germani A Zacheo J Kajstura A Di Carlo G Borsellino, et al. 2005 Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation Circulation Research 97 e73 e83 10.1161/01.RES.0000186276.06104. 04 16166556 1:CAS:528:DC%2BD2MXhtVymt7bN
77. A Germani F Limana MC Capogrossi 2007 Pivotal advances: high-mobility group box 1 protein-a cytokine with a role in cardiac repair Journal of Leukocyte Biology 81 41 45 10.1189/jlb.0306165 16940333 1:CAS:528: DC%2BD2sXktVaitw%3D%3D (Pubitemid 46021250)
78. A Rossini A Zacheo D Mocini P Totta A Facchiano R Castoldi, et al. 2008 HMGB1-stimulated human primary cardiac fibroblasts exert a paracrine action on human and murine cardiac stem cells Journal of Molecular and Cellular Cardiology 44 683 693 10.1016/j.yjmcc.2008.01.009 18328501 1:CAS:528:DC%2BD1cXmsVOqsL4%3D
79. WA Border NA Noble 1994 Transforming growth factor beta in tissue fibrosis The New England Journal of Medicine 331 1286 1292 10.1056/ NEJM199411103311907 7935686 1:CAS:528:DyaK2MXitlGksrs%3D (Pubitemid 24333194)
80. S Rosenkranz 2004 TGF-beta1 and angiotensin networking in cardiac remodeling Cardiovascular Research 63 423 432 10.1016/j.cardiores.2004.04.030 15276467 1:CAS:528:DC%2BD2cXmtVWitbs%3D (Pubitemid 38970186)
81. W Briest L Homagk B Rassler B Ziegelhoffer-Mihalovicova H Meier A Tannapfel, et al. 2004 Norepinephrine-induced changes in cardiac transforming growth factor-beta isoform expression pattern of female and male rats Hypertension 44 410 418 10.1161/01.HYP.0000141414.87026.4d 15326086 1:CAS:528:DC%2BD2cXnslenu7k%3D (Pubitemid 39281488)
82. R Jain PW Shaul Z Borok BC Willis 2007 Endothelin-1 induces alveolar epithelial-mesenchymal transition through endothelin type A receptor-mediated production of TGF-beta1 American Journal of Respiratory Cell and Molecular Biology 37 38 47 10.1165/rcmb.2006-0353OC 17379848 1:CAS:528: DC%2BD2sXntlyksbw%3D (Pubitemid 46999535)
83. AA Lee WH Dillmann AD McCulloch FJ Villarreal 1995 Angiotensin II stimulates the autocrine production of transforming growth factor-beta 1 in adult rat cardiac fibroblasts Journal of Molecular and Cellular Cardiology 27 2347 2357 10.1016/S0022-2828(95)91983-X 8576949 1:CAS:528:DyaK2MXovFOhsLs%3D
84. FB Engel PC Hsieh RT Lee MT Keating 2006 FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction Proceedings of the National Academy of Sciences of the United States of America 103 15546 15551 10.1073/pnas.0607382103 17032753 1:CAS:528:DC%2BD28XhtFCjtLbP (Pubitemid 44625629)
85. FB Engel M Schebesta MT Duong G Lu S Ren JB Madwed, et al. 2005 p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes Genes & Development 19 1175 1187 10.1101/gad.1306705 1:CAS:528: DC%2BD2MXksFKnurc%3D (Pubitemid 40696184)
86. DJ Lips LJ deWindt DJ van Kraaij PA Doevendans 2003 Molecular determinants of myocardial hypertrophy and failure: alternative pathways for beneficial and maladaptive hypertrophy European Heart Journal 24 883 896 10.1016/S0195-668X(02)00829-1 12714020 1:CAS:528:DC%2BD3sXjtFWms74%3D (Pubitemid 36559982)
87. N De Angelis F Fiordaliso R Latini L Calvillo M Funicello M Gobbi, et al. 2002 Appraisal of the role of angiotensin II and aldosterone in ventricular myocyte apoptosis in adult normotensive rat Journal of Molecular and Cellular Cardiology 34 1655 1665 10.1006/jmcc.2002.2115 12505063 (Pubitemid 35454480)
88. M Jessup WT Abraham DE Casey AM Feldman GS Francis TG Ganiats, et al. 2009 2009 focused update: ACCF/AHA Guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 1977 2016 10.1161/CIRCULATIONAHA.109.192064 19324967
89. WJ Remme 2007 Beta blockers or angiotensin-converting-enzyme inhibitor/angiotensin receptor blocker: what should be first? Cardiol Clin 25 581 594 10.1016/j.ccl.2007.09.004 18063162 vii. (Pubitemid 350193269)
90. CM Ford S Li JG Pickering 1999 Angiotensin II stimulates collagen synthesis in human vascular smooth muscle cells. Involvement of the AT(1) receptor, transforming growth factor-beta, and tyrosine phosphorylation Arteriosclerosis, Thrombosis, and Vascular Biology 19 1843 1851 10446062 1:CAS:528:DyaK1MXls1OqtL8%3D
91. B Jiang S Xu X Hou DR Pimentel RA Cohen 2004 Angiotensin II differentially regulates interleukin-1-beta-inducible NO synthase (iNOS) and vascular cell adhesion molecule-1 (VCAM-1) expression: role of p38 MAPK The Journal of Biological Chemistry 279 20363 20368 10.1074/jbc.M314172200 15001568 1:CAS:528:DC%2BD2cXjs1Wgs74%3D (Pubitemid 38623482)
92. XL Chen PE Tummala MT Olbrych RW Alexander RM Medford 1998 Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells Circulation Research 83 952 959 9797345 1:CAS:528: DyaK1cXnt1yju78%3D
93. PE Tummala XL Chen CL Sundell JB Laursen CP Hammes RW Alexander, et al. 1999 Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: a potential link between the renin-angiotensin system and atherosclerosis Circulation 100 1223 1229 10484544 1:CAS:528:DyaK1MXmsVart7w%3D
94. I Nakayama Y Kawahara T Tsuda M Okuda M Yokoyama 1994 Angiotensin II inhibits cytokine-stimulated inducible nitric oxide synthase expression in vascular smooth muscle cells The Journal of Biological Chemistry 269 11628 11633 7512570 1:CAS:528:DyaK2cXis1ahtbg%3D
95. B Jiang S Xu X Hou DR Pimentel P Brecher RA Cohen 2004 Temporal control of NF-kappaB activation by ERK differentially regulates interleukin-1beta- induced gene expression The Journal of Biological Chemistry 279 1323 1329 10.1074/jbc.M307521200 14581482 1:CAS:528:DC%2BD2cXhtVyqtg%3D%3D (Pubitemid 38082657)
96. B Jiang P Brecher RA Cohen 2001 Persistent activation of nuclear factor-kappaB by interleukin-1beta and subsequent inducible NO synthase expression requires extracellular signal-regulated kinase Arteriosclerosis, Thrombosis, and Vascular Biology 21 1915 1920 10.1161/hq1201.099424 11742864 1:CAS:528:DC%2BD38XivFeq
97. B Jiang S Xu P Brecher RA Cohen 2002 Growth factors enhance interleukin-1 beta-induced persistent activation of nuclear factor-kappa B in rat vascular smooth muscle cells Arteriosclerosis, Thrombosis, and Vascular Biology 22 1811 1816 10.1161/01.ATV.0000037679.60584.3F 12426209 1:CAS:528:DC%2BD38Xot1OitbY%3D (Pubitemid 35315766)